Despite legislative attention from Congress in the 1980s, diagnostic research into rare diseases is not lucrative enough to garner sufficient private funding. 

This response to an article suggests that the authors erred in committing the errors they critique.

Preethi Subbiah joins Ethics Talk to discuss her article, coauthored with Dr Richard M. Scheffler: “When Does Private Equity Ownership of Physician Practices Violate ‘First, Do No Harm’?”

Dr Amber R. Comer joins Ethics Talk to discuss her article, coauthored with Dr Jake Young: “Physician Engagement With Private Equity Firms.”

Private equity margin maximization and profit-making strategies focus on acquisition, short-term ownership, and sale of health care entities, including residency program opportunities.

Private equity investments in health care have grown to over $750 billion in the past decade and include every segment of the US health sector.

Private equity investments in health care raise several clinical and ethical questions about private equity’s influence on clinicians’ practices.

Private equity companies have no ethical or legal duties to patients and strive to maximize financial returns for their investors.

One driver of the corporatization of medicine has been private equity firms’ acquisitions of physician practices.

Dr Jake Young joins Ethics Talk to discuss his article: “AMA Code of Medical Ethics’ Opinions Related to Robotic Surgery.”